AACI Asks NCI for Better Definitions Of Center Types, Development Of Objectives, Priorities
In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress
NCI Tells How It Would Spend FY 1978 Research Money
Shubik Named To Another NCA Term In Surprise Move
Rauscher Decision Put Off To July 1: Administration Backs Pay Raise Bill
New GAO Report Critical Of federal Effort Against Environmental Carcinogenesis
RFPs Available, Contract Awards, Sole Source Negotiations
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
